Drug resistance and DNA repair

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• DNA repair mechanisms are crucial for cellular survival and can confer resistance to anticancer drugs that target DNA.
• Understanding DNA repair pathways is essential for developing effective cancer therapies.
• The precise role of specific DNA lesions, such as O(6)-alkylguanine adducts and DNA cross-links, in drug-induced cytotoxicity is not fully elucidated.

Purpose of the Study:

• To review current knowledge on DNA repair and its role in anticancer drug resistance.
• To highlight advancements in understanding DNA adduct repair and identify knowledge gaps in DNA cross-link repair.
• To discuss the complexity of drug sensitivity/resistance phenotypes and the application of novel DNA repair assays.

Main Methods:

• Review of existing literature on DNA repair and drug resistance.
• Discussion of molecular cloning of DNA repair genes (e.g., E. coli ada gene).
• Exploration of enzymology and molecular biology of DNA cross-link repair.
• Application of assays for DNA repair fidelity and intragenomic heterogeneity.

Main Results:

• Advancements in understanding O(6)-alkylguanine adduct repair due to gene cloning, but its role in mammalian cells remains unclear.
• Limited progress in the enzymology and molecular biology of DNA cross-link repair, despite their importance for bifunctional alkylating agents and platinum compounds.
• Drug sensitivity and resistance are complex, influenced by DNA damage effects on cell metabolism.
• Few direct correlations exist between DNA repair capacity and cellular sensitivity, but new assays show promise.

Conclusions:

• Further research is needed to fully understand the role of DNA repair in drug resistance.
• Identifying and characterizing human DNA repair genes is a key area for future investigation.
• Novel assays measuring DNA repair fidelity and heterogeneity may reveal subtle differences in drug-sensitive and resistant cell lines.